How Breakthrough T1D Is Pursuing Multiple Paths to Better Type 1 Diabetes Treatment

The organization formerly known as JDRF supports research across several different approaches—from immune therapies to cell replacement—alongside tools that help people manage diabetes day-to-day.

cureresearchclinical trial

Key takeaways

Breakthrough T1D funds research across multiple pathways, including immune therapies, cell replacement approaches, and disease-modifying treatments, rather than focusing on a single strategy.
The organization has supported the development of continuous glucose monitors and closed-loop artificial pancreas systems that help people track blood sugar and manage diabetes daily.
Breakthrough T1D's work includes both research aimed at preventing type 1 diabetes from developing and treatments for people already living with the condition.

A Multi-Pathway Research Strategy

Breakthrough T1D, formerly known as JDRF, supports research aimed at preventing, treating, and potentially curing type 1 diabetes. The organization funds work across several different research pathways rather than betting everything on one approach. These include disease-modifying therapies—treatments designed to slow or change how type 1 diabetes develops—cell replacement and regeneration strategies, and immune therapies that aim to stop the autoimmune attack that causes type 1 diabetes.

Technology That Improves Daily Life

Breakthrough T1D's work goes beyond cure research. The organization has played a role in advancing diabetes technology, including continuous glucose monitors, which are small devices that track blood sugar throughout the day. The organization has also funded research on closed-loop artificial pancreas systems—devices that automatically adjust insulin based on glucose readings. These tools help people manage type 1 diabetes day-to-day while cure-focused research continues.

Supporting Research Across Multiple Fronts

Breakthrough T1D's leadership and staff bring deep scientific expertise to their work. The organization pursues research aimed at preventing diabetes onset in people at risk as well as treatments for those already living with type 1 diabetes. This multi-pronged approach reflects a commitment to making progress on several fronts simultaneously.

Evidence label

Source: YouTube community video. Evidence type: Community video — lay discussion, not peer-reviewed research. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.